✦ LIBER ✦

Effect of Different Doses of Estrogen on the Nigrostriatal Dopaminergic System in Two 6-Hydroxydopamine-Induced Lesion Models of Parkinson’s Disease

✍ Scribed by Marcela Ferreira Cordellini; Giovana Piazzetta; Karin Cristine Pinto; Ana Márcia Delattre; Francesca Matheussi; Ruither O. G. Carolino; Raphael Escorsim Szawka; Janete A. Anselmo-Franci; Anete Curte Ferraz

Publisher: Springer
Year: 2011
Tongue: English
Weight: 262 KB
Volume: 36
Category: Article
ISSN: 0364-3190
DOI: 10.1007/s11064-011-0428-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of dopamine D3and serotonin 5-HT1Ar

Role of dopamine D3and serotonin 5-HT1Areceptors inl-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson’s disease

✍ Manfred Gerlach; Gerd D. Bartoszyk; Peter Riederer; Olivia Dean; Maarten van den 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 284 KB

Effects of Zingerone [4-(4-Hydroxy-3-Met

Effects of Zingerone [4-(4-Hydroxy-3-Methoxyphenyl)-2-Butanone] and Eugenol [2-Methoxy-4-(2-Propenyl)Phenol] on the Pathological Progress in the 6-Hydroxydopamine-Induced Parkinson’s Disease Mouse Model

✍ Hideaki Kabuto; Tomoko T. Yamanushi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 354 KB

Effects of CB1 cannabinoid receptor modu

Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease

✍ Gregorio Segovia; Francisco Mora; Alan R. Crossman; Jonathan M. Brotchie 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract The present study was designed to determine the potential of CB1 cannabinoid receptor modulating compounds in the treatment of L‐3,4‐dihydroxyphenylalanine (L‐dopa)–induced dyskinesia in Parkinson's disease. In the reserpine‐treated rat model of parkinsonism, administration of a high do